Industry & Services >> Analyst Interviews >> October 8, 2001
Instrument Industry Outlook: Paul Knight – Thomas Weisel Partners
PAUL R. KNIGHT, CFA, is a Founding Partner of Thomas Weisel Partners
LLC, co-Head of Healthcare Research, and Head of the Life Science
Research Group. Prior to his position at Thomas Weisel Partners, Mr.
Knight spent 11 years at Salomon Brothers and NatWest Securities. Over
his 14-year Wall Street career, he has been a top-ranked analyst by
Institutional Investor, The Greenwich Survey and The Wall Street
Journal. For 10 years, Mr. Knight has been ranked as having the best Buy
or Sell stock ratings, most recently in the 2000 and 2001 Wall Street
Journal surveys. He is a Chartered Financial Analyst and has received a
BS in Economics from the University of Nebraska and an MBA from the
George Washington University. Profile
TWST: What is the broad definition of your coverage area?
Mr. Knight: I was the first analyst on Wall Street to cover instrument
stocks and the instrument industry as a discrete investment